Solution of methodological problems in prorenin measurement and investigations of tissue renin-angiotensin systems in the female reproductive tract

Danish Medical Bulletin

Volumn 44, Issue 5, 1997, Pages 486-498

  Hagemann, Arne ^a,b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; PRORENIN; RENIN; TRYPSIN;

ANGIOGENESIS; CATTLE; DECIDUALIZATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE GENITAL SYSTEM; HUMAN; NEPHRECTOMY; NONHUMAN; OOCYTE MATURATION; OVARY; OVARY FOLLICLE MATURATION; OVULATION; PLACENTA; PLASMA RENIN ACTIVITY; PREGNANCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPECIES DIFFERENCE; STEROIDOGENESIS; SWINE; TISSUE DISTRIBUTION; UTERUS;

ANIMALS; ENZYME PRECURSORS; FEMALE; HUMANS; OVARY; PLACENTA; PREGNANCY; RENIN; RENIN-ANGIOTENSIN SYSTEM; UTERUS;

EID: 0030697845     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (203)

1. Johannessen A, Nielsen AH, Jacobsen J, Poulsen K: On the measurement of inactive renin in rat plasma: activation by trypsin generates interfering tetradecapeptide-like material and destroys angiotensinogen. J Hypertens 1989; 7: 395-402.
2. Johannessen A, Nielsen AH, Poulsen K: Measurement of inactive renin in rat plasma: effect of nephrectomy and sialoadenectomy on the plasma concentration. J Hypertens 1990; 8: 345-349.
3. Hagemann A, Nielsen AH, Poulsen K. Prorenin is present in plasma from nephrectomized rats: interfering sulphydryl enzyme. J Hypertens 1992; 10: 959-962.
4. Nielsen AH, Johannessen A, Poulsen K: Adrenalectomy causes a delayed increase of inactive plasma renin in rats. J Hypertens 1991; 9: 239-240.
5. Johannessen A, Nielsen AH, Poulsen K: Sexual dimorphism of inactive renin in rat plasma. J Clin Exp Hypertens - theory and practice 1990; A12(8): 1405-1417.
6. Nielsen AH, Hagemann A, Poulsen K. Effect of gonadotropins and pregnancy on prorenin and renin in the rat. Clin Exp Pharmacol Physiol 1991; 18: 419-424.
7. Hagemann A, Dantzer V, Nielsen AH, Poulsen K. Renin and prorenin in reproductive tissues during gestation in pigs and cattle. Clin Exp Pharmacol Physiol 1993; 20: 41-50.
8. Hagemann A, Nielsen AH, Dantzer V, Avery B, Poulsen K. Measurement and identification of prorenin and renin in ovarian follicular fluid from cattle and pig. Clin Exp Pharmacol Physiol 1992; 19: 267-273.
9. Hagemann A, Nielsen AH, Assey RJ, Hyttel P, Boland MP, Roche JF, Poulsen K. Prorenin and active renin concentrations in ovarian follicular fluid increase after the LH peak in superovulated heifers. Clin Exp Pharmacol Physiol 1994; 21: 639-648.
10. Hagemann A, Nielsen AH, Avery B, Poulsen K. In-vitro incubation of bovine ovarian follicles: indications for an active and regulated reninangiotensin system. Clin Exp Pharmacol Physiol 1994; 21: 569-575.
11. Nielsen AH, Hagemann A, Svenstrup B, Nielsen J, Poulsen K. Angiotensin II receptor density in bovine ovarian follicles relates to tissue renin and follicular size. Clin Exp Pharmacol Physiol 1994; 21: 463-469.
12. Katz SA, Malvin RL, Renin secretion: control, pathways, and glycosylation. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing, 1993: 24.1-24.13.
13. Peach MJ, Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57: 313-370.
14. Nielsen AH, Poulsen K. Is prorenin of physiological and clinical significance? J Hypertens 1988; 6: 949-958.
15. Sealey JE, Atlas SA, Laragh JH, Prorenin and other large molecular weight forms of renin. Endocr Rev 1980; 1: 365-391.
16. Barren JD, Eggena P, Sowers JR, Sambhi MP. Effects of stimulation of renin release on trypsin-activable renin in rat plasma. Am J Physiol 1982; 243: E206-E212.
17. Glorioso N, Madeddu P, Dessi Fulgheri P, Fois G, Meloni F, Bandiera F, et al. Trypsin-activatable inactive renin in rat plasma. Clin Sci 1983; 64: 137-140.
18. Vandongen R, Poessee M, Strang KD, Birkenhager WH. Evidence that 'inactive' renin is produced outside the kidney of the rat. Clin Sci Mol Med 1977; 53: 189-191.
19. de Keijzer MH, Provoost AP, Derkx FH. Absence of activation in vitro of renin in rat plasma. Clin Sci 1982; 62: 435-437.
20. Osmond DH, Cooper RM, Cryoactivation and tryptic activation of blood 'prorenin' in normal man and animals. Can J Physiol Pharmacol 1977; 56: 792-805.
21. Doi Y, Franco Saenz R, Mulrow PJ. Evidence for an extrarenal source of inactive renin in rats. Hypertension 1984; 6: 627-632.
22. Hare GM, Ioannou P, Dubiski S, Osmond DH. Regulated systemic activation of rat plasma prorenin. Hypertension 1987; 10: 122-126.
23. Miyazaki S, Sakanaka A, Chimori K, Kosaka J, Goi R, Dodo S, et al. Reno-submandibular axis controls release of extrarenal inactive renin. J Hypertens 1988; 6: 33-40.
24. Madeddu P, Glorioso N, Dessi-Fulgheri P, Oppes M, Tonolo G, Bandiera F. et al. Changes in circulating active and inactive renin after bilateral nephrectomy in the rat. IRCS Med Sci 1984; 12: 1143-1144.
25. Barren JD, Eggena P. Effects of trypsin on the measurement of inactive renin in rat plasma by radio-immunoassay: decrease in inactive renin following nephrectomy. J Hypertens 1988; 6: 49-55.
26. Hare GM, Osmond DH. New renin-angiotensin from plasma prorenin? Am J Hypertens 1990; 3: 196-203.
27. Swales JD. A perspective of extrarenal renin. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing, 1993: 48.1-48.14.
28. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79: 1-6.
29. Bumpus FM, Pucell AG, Daud AI, Husain A. Angiotensin II: an intraovarian regulatory peptide. Am J Med Sci 1988; 295: 406-408.
30. Lumbers ER, Renin, uterus and amniotic fluid. In: Robertson JIS, Nicholls MG, eds. The Renin-angiotensin system. London: Gower Medical Publishing, 1993: 45.1-45.12.
31. Sealey JE, Quimby FW, Itskovitz J, Rubattu S. The ovarian renin-angiotensin system. Front Neuroendocrinol 1990; 11: 213-237.
32. Hagemann A, Nielsen AH, Poulsen K. The uteroplacental renin-angiotensin system: a review. Exp Clin Endocrinol 1994; 102: 251-260.
33. Poulsen K, Nielsen AH. The measurement of renin. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing. 1993: 13.1-13.12.
34. Menard J, Bews J, Heusser C. A multirange ELISA for the measurement of plasma renin in humans and primates. J Hypertens Suppl 1984; 2: S275-S278.
35. Simon D, Badouaille G, Pau B, Guyene TT, Corvol P, Menard J. Measurement of active renin by the 4G1 anti-human renin monoclonal antibody. Clin Exp Hypeitens A 1987; 9: 1333-1340.
36. Nussberger J, de Gasparo M, Juillerat L, Guyenne TT, Mooser V, Waeber B, et al. Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A. Clin Exp Hypertens A 1987; 9: 1353-1366.
37. Schalekamp MADH, Derkx FHM. Inactive renin - biochemical aspects. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing, 1993: 6.1-6.13.
38. Price Jones MJ, Charlton PA, Bessant CM, Harrison TM, Darke BM, Lees WE, et al. Analysis of latent forms of renin using antibodies raised against the propart segment of human prorenin: validation with representative samples of ovarian cyst and follicular fluids. Clin Exp Hypertens 1993; 15: 619-640.
39. Poulsen K, Jørgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab 1974; 39: 816-825.
40. Skeggs LT, Kahn JR, Lentz K, Shumway NP. The preparation, purification, and amino acid sequence of a polypeptide renin substrate. J Exp Med 1957; 106: 439-453.
41. Jacobsen J, Poulsen K, Characterization of angiotensin I, II, and III from mouse as position-5 isoleucine angiotensins. An HPLC Study. J Hypertens 1985; 3: 155-157.
42. Menard J, Clauser E, Bouhnik J, Corvol P. Angiotensinogen: biochemical aspects. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing. 1993: 8.1-8.10.
43. Barrett JD, Eggena P, Trypsin activation of inactive renin: plasma blanks and angiotensin I radioimmunoassay. Can J Physiol Phannacol 1991; 69: 1315-1320.
44. Jindra AJ, Bultas J, Ort J, Kvetnansky R. Investigation of human and rat inactive renin in plasma and kidney. Can J Physiol Pharmacol 1991; 69: 1341-1349.
45. Mailing C, Poulsen K. A direct radioimmunoassay for plasma renin in mice and its evaluation. Biochim Biophys Acta 1977; 491: 532-541.
46. Haas E, Lamfrom H, Goldblatt H. A simple method for the extraction and partial purification of renin. Arch Biochem Biophys 1954; 48: 256-260.
47. Konrads A, Hummerich W, Vlaho M, Meurer KA. Effects of furosemide and orthostasis on active and inactive renin in normal and anephric man. Eur J Clin Invest 1981; 11: 105-109.
48. Evans DB, Cornette JC, Sharma SK. Effect of angiotensinogen concentration on renin activity following nephrectomy and adrenalectomy: implications in the activation of plasma prorenin. Clin Exp Hypertens A 1990; 12: 1473-1487.
49. Campbell DJ. Metabolism of prorenin, renin, angiotensinogen and the angiotensins by tissues. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system London: Gower Medical Publishing, 1993: 23.1-23.23.
50. Osmond DH, Sealey JE, McKenzie JK. Activation and function of prorenin: different viewpoints Can J Physiol Phannacol 1991; 69: 1308-1314.
51. Johannessen A, Nielsen AH, Jacobsen J, Poulsen K. Solution of methodological problems in measurement of inactive renin in rat plasma using trypsin activation, and the effect of nephrectomy and sialo-adenectomy on inactive plasma renin. J Hypertens Suppl 1989; 7: S224-S225.
52. Kim S, Hosoi M, Nakajima K, Yamamoto K. Biochemical and immunological differences between plasma inactive renin from normal and nephrectomized rats. Can J Physiol Pharmacol 1991; 69: 1350-1354.
53. Kim S, Hosoi M, Nakajima K, Yamamoto K. Immunological evidence that kidney is primary source of circulating inactive prorenin in rats. Am J Physiol 1991; 260: E526-E536.
54. Nielsen AH, Poulsen K. Evidence for a predominant renal secretion and clearance of inactive plasma renin. studied by in vivo inhibition of protein synthesis. J Hypertens 1988; 6: 129-137.
55. Danser AHJ, Admiraal PJJ, Derkx FHM, Ban de Bruyn JH, Schalekampen MADH. Changes in plasma renin and angiotensin run in parallel after nephrectomy. J Hypenens 1993; 11 (suppl 5): S238-S239.
56. Campbell WG, Gahnem F, Catanzaro DF, James GD, Camargo MJF, Laragh JH, et al. Plasma and renal prorenin/renin. renin mRNA. and blood pressure in Dahl salt-sensitive and salt-resistant rats. Hypertension 1996; 27: 1121-1133.
57. Tokita Y, Franco-Saenz R, Mulrow PJ, Ganten D. Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mRen2)27. Endocrinology 1994; 134: 253-257.
58. De Vito E, Martinez de Melián ER, Guardia DC. Activation of renal renin by a protein plasma fraction: a novel enzymatic mechanism. Comp Biochem Physiol B 1996; 113: 433-438.
59. Nielsen AH, Gotfredsen P, Nielsen PB, Hyttel P, Poulsen K. Measurement of renin and prorenin in cattle, hog and horse. Comp Biochem Physiol A 1991; 100: 127-131.
60. Schultze D, Brunswig B, Mukhopadhyay AK, Renin and prorenin-like activities in bovine ovarian follicles. Endocrinology 1989; 124: 1389-1398.
61. Nielsen AH, Johannessen A, Poulsen K. Inactive plasma renin exhibits sex difference in mice. Clin Sci 1989; 76: 439-446.
62. Glorioso N, Troffa C, Laragh JH, Atlas SA, Marion D, Sealey JE. The cat: an animal model for studies of inactive renin. Am J Physiol 1987; 252: E509-E518.
63. Hardman JA, Hort YJ, Catanzaro DF, Tellam JT, Baxter JD, Morris BJ, et al. Primary structure of the human renin gene. DNA 1984; 3: 457-468.
64. Pandey KM, Inagami T. Regulation of renin angiotensins by gonadotropic hormones in cultured murine Leydig tumor cells. Release of angiotensin but not renin. J Biol Chem 1986; 261: 3934-3938.
65. Kim S, Shinjo M, Tada M, Usuki S, Fukamizu A, Miyazaki H, et al. Ovarian renin gene expression is regulated by follicle-stimulating hormone. Biochem Biophys Res Commun 1987; 146: 989-995.
66. Sealey JE, Goldstein M, Pitarresi T, Kudlak TT, Glorioso N, Fiamengo SA, et al. Prorenin secretion from human testis: no evidence for secretion of active renin or angiotensinogen J Clin Endocrinol Metab 1988; 66: 974-978.
67. Inagami T. Renin in testis and epididymis. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Cower Medical Publishing, 1993: 47.1-47.5.
68. Sealey JE, Atlas SA, Glorioso N, Manapat H, Laragh JH. Cyclical secretion of prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone. Proc Natl Acad Sci U S A 1985; 82: 8705-8709.
69. Sealey JE, Cholsi I, Glorioso N, Troffa C, Weintraub ID, James G, et al. Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J Clin Endocrinol Metab 1987; 65: 1-5.
70. De Hertogh R, Vankrieken L, de Gasparo M, Thomas K. Immunoradiometric assays of total renin and gonadotropins in serum during the menstrual cycle. Fertil Steril 1989; 52: 209-215
71. Blankestijn PJ, Derkx FH, Van Geelen JA, De Jong FH, Schalekamp MA. Increase in plasma prorenin during the menstrual cycle of a bilaterally nephrectomized woman. Br J Obstet Gynaecol 1990; 97: 1038-1042.
72. Itskovitz J, Sealey JE, Glorioso N, Rosenwaks Z. Plasma prorenin response to human chorionic gonadotropin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations. Proc Natl Acad Sci U S A 1987; 84: 7285-7289.
73. Paulson RJ, Do YS, Hsueh WA, Lobo RA. Gradients of prorenin and active renin in ovarian venous and peripheral venous blood samples obtained simultaneously. Am J Obstet Gynecol 1988; 159: 1575-1579.
74. Hsueh WA, Luetscher JA, Carlson EJ, Grislis G, Fraze E, McHargue A. Changes in active and inactive renin throughout pregnancy. J Clin Endocrinol Metab 1982; 54: 1010-1016.
75. Sealey JE, Wilson M, Morganti AA, Zervoudakis I, Laragh JH. Changes in active and inactive renin throughout normal pregnancy. Clin Exp Hypertens A 1982; 4: 2373-2384.
76. Derkx FH, Alberda AT, De Jong FH, Zeilmaker FH, Makovitz JW, Schalekamp MA. Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure. J Clin Endocrinol Metab 1987; 65: 349-354.
77. Poisner AM, Wood GW, Poisner R. Release of inactive renin from human fetal membranes and isolated trophoblasts. Clin Exp Hypertens A 1982; 4: 2007-2017.
78. Brar HS, Do YS, Tain HB, Valenzuela GJ, Murray RD, Longo LD, et al. Uteroplacental unit as a source of elevated circulating prorenin levels in normal pregnancy. Am J Obstet Gynecol 1986; 155: 1223-1226.
79. Lenz T, James GD, Laragh JH, Sealey JE. Prorenin secretion from human placenta perfused in vitro. Am J Physiol 1991; 260: E876-E882.
80. Rubattu S, Quimby FW, Sealey JE. Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid. J Hypertens 1991; 9: 525-535.
81. Howard RB, Husain A. Rat ovarian angiotensin II receptors, renin, and angiotensin I-converting enzyme during pregnancy and the postpartum period. Biol Reprod 1992; 47: 925-930.
82. Sealey JE, Glorioso N, Itskovitz J, Laragh JH. Prorenin as a reproductive hormone. New form of the renin system. Am J Med 1986; 81: 1041-1046.
83. Fowler WLJ, Johnson JA, Kurz KD, Kilfoil J, Love S, Payne CG. Role of the renin-angiotensin system in maintaining arterial pressure in conscious pregnant rats. Endocrinology 1981; 109: 290-295.
84. Brown JJ, Davis DL, Lever AF, Robertson JIS. Variations in plasma renin during the menstrual cycle. Br Med J 1964; 2: 1114-1115.
85. Pipkin FB, The fetal renin-angiotensin system. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing, 1993: 51.1-51.10.
86. Stakemann G. A renin-like presser substance found in the placenta of the cat. Acta Pathol Microbiol Scand 1960; 50: 350-354.
87. Kim S, Shinjo M, Fukamizu A, Miyazaki H, Usuki S, Murakami K. Identification of renin and renin messenger RNA sequence in rat ovary and uterus. Biochem Biophys Res Commun 1987; 142: 169-175.
88. Rawashdeh NM, Rose JC, Kerr DR. Age-dependent differences in active and inactive renin in the lamb fetus. Biol Neonate 1991; 60: 243-248.
89. Hackenthal E, Metz J, Poulsen K, Rix E, Taugner R. Renin in the uterus of non-pregnant mice. Immunocytochemical, ultrastructural and biochemical studies. Histochemistry 1980; 66: 229-238.
90. Skinner SL, Lumbers ER, Symonds EM. Renin concentration in human fetal and maternal tissues. Am J Obstel Gynecol 1968; 101: 529-533.
91. Warren AY, Craven DJ, Symonds EM. Production of active and inactive renin by cultured explants from the human female genital tract. Br J Obstet Gynaecol 1982; 89: 628-632.
92. Lenz T. Scaley JE, August P, James GD, Laragh JH. Tissue levels of active and total renin, angiotensinogen, human chorionic gonadotropin. cstradiol, and progesterone in human placentas from different methods of delivery J Clin Endocrinol Metab 1989; 69: 31-37.
93. Poisner AM, Wood GW, Poisner R, Inagami T, Localization of renin in trophoblasts in human chorion laeve at term pregnancy. Endocrinology 1981; 109: 1150-1155.
94. Poisner AM, Wood GW, Poisner R, Inagami T. Renin and inactive renin in human amnion at term pregnancy. Proc Soc Exp Biol Med 1982; 169: 4-6.
95. Raju GC, Lee YS, Immunohistochemical demonstration of renin in the endometrium. Ann Acad Med Singapore 1989; 18: 345-347.
96. Jikihara H, Poisner AM, Hirsch R, Handwerger S. Human uterine decidual macrophages express renin. J Clin Endocrinol Metah 1995; 80: 1273-1277.
97. Bing J, Faarup P. A quantitative and qualitative study of renin in the different layers of the rabbit uterus. Acta Pathol Microbiol Scand 1966; 67: 169-179.
98. Dzau VJ, Gonzalez D, Ellison K, Churchill S, Emmett N. Characterization of purified rabbit uterine renin: influence of pregnancy on uterine inactive renin. Endocrinology 1987; 120: 358-364.
99. Jacobsen J, Poulsen K. Characterization of inactive renin in mouse amniotic fluid. J Hypertens 1984; 2: 523-527.
100. Itskovitz J, Rubattu S, Levron J, Sealey JE. Highest concentrations of proremn and human chorionic gonadotropin in gestational sacs during early human pregnancy. J Clin Endocrinol Metab 1992; 75: 906-910.
101. Skinner SL, Cran EJ, Gibson R, Taylor R, Walters WA, Calt KJ. Angiotensins I and II, active and inactive renin, renin substrate, renin activity, and angiotensinase in human liquor amnii and plasma. Am J Obstet Gynecol 1975; 121: 626-630.
102. Hackenthal E, Hackenthal R, Hilgenfeldt U. Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes. Biochim Biophys Acta 1978; 522: 574-588.
103. Sapolsky AI, Woessner JF, Multiple forms of cathepsin D from bovine uterus. J Biol Chem 1972; 247: 2069-2076.
104. Inagami T. Intracellular renin: validation and function In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medicak Publishing, 1993: 30.1-30.8.
105. Drury PL, Edwards CR. Studies on the cryoactivation of human renin. Clin Chim Acta 1981; 113: 319-323.
106. Björkman N, Dantzer V, Leiser R. Comparative placentation in laboratory animals: a review Scan J Lab Anim Sci 1989; 4: 129-158.
107. Rix E, Hackenthal E, Metz J, Poulsen K, Taugner R. Renin in the uterus of pregnant mice. Immunocytochemical, ultrastructural and biochemical studies. Histochemistry 1980; 68: 253-263.
108. Downing GJ, Poisner AM, Barnea ER. First-trimester villous placenta has high prorenin and active renin concentrations. Am J Obstet Gynecol 1995; 172: 864-867.
109. Ihara Y, Taii S, Mori T. Expression of renin and angiotensinogen genes in the human placental tissues. Endocrinol Jpn 1987; 34: 887-896.
110. Shaw KJ, Do YS, Kjos S, Anderson PW, Shinagawa T, Dubeau L, et al. Human decidua is a major source of renin. J Clin Invest 1989; 83: 2085-2092.
111. Acker GM, Galen FX, Devaux C, Foote S, Papernik E, Pesty A, et al. Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab 1982; 55: 902-909.
112. Symonds EM, Stanley MA, Skinner SL, Production of renin by in vitro cultures of human chorion and uterine muscle. Nature 1968; 217: 1152-1153.
113. Poisner AM, Thrailkill K, Poisner R, Handwerger S. Cyclic AMP as a second messenger for prorenin release from human decidual cells. Placenta 1991; 12: 263-267.
114. Eskildsen PC. Place of renin formation in rabbit uterus. II. Renin in intraocular endometrial and myometrial transplants. Acta Pathol Microbiol Scand A 1971; 79: 123-133.
115. Jorgensen J, In vitro effects of various metabolic inhibitors on the formation of inactive renin and the loss of renin in rabbit uterine tissue. Acta Endocrinol Copenh 1981; 96: 281-288.
116. Johnson IR. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during menstrual cycles controlled by oral contraceptive preparations. Br J Obslet Gynaecol 1980; 87: 883-888.
117. Leuz T, Sealey JE, Tewksbury DA. Regional distribution of the angiotensinogens in human placentae. Placenta 1993; 14: 695-699.
118. Skinner SL, Lumbers ER, Symonds EM. Analysis of changes in the renin-angiotensin system during pregnancy. Clin Sci 1972; 42: 479-488.
119. Jorgensen J. Concentrations of renin and renin substrate in plasma of rabbits during pregnancy and the post partum period. Acta Pathol Microbiol Scand A 1974; 82: 742-746.
120. Carver JG, Mott JC. Renin substrate in plasma of unanaesthetized pregnant ewes and their foetal lambs J Physiol Lond 1978; 276: 395-402.
121. Lieberman J, Sastre A. Angiotensin-converting enzyme activity in postmortem human tissues. Lab Invest 1983; 48: 711-717.
122. Sim MK, Seng KM. Development of angiotensin converting enzyme in fetal lung and placenta of the rat and human. Clin Exp Pharmacol Physiol 1984; 11: 497-501.
123. Naruse M, Naruse K, Kurimoto F, Sakurai H, Yoshida S, Toma H, et al. Evidence for the existence of des-Asp1-angiotensin II in human uterine and adrenal tissues. J Clin Endocrinol Metab 1985; 61: 480-483.
124. Kalenga MK, De Hertogh R, Whitebread S, Vankrieken L, Thomas K, de Gasparo M. [Distribution of the concentrations of angiotensin II (A II). A II receptors, hPL. prolactin, and steroids in human fetal membranes]. Rev Fr Gynecol Obstet 1991; 86: 585-591.
125. De Silva PE, Husain A, Smeby RR, Khairallah PA. Measurement of immunoreactive angiotensin peptides in rat tissues: some pitfalls in angiotensin II analysis. Anal Biochem 1988; 174: 80-87.
126. Craven DJ, Warren AY, Symonds EM. Generation of angiotensin I by human chorion-decidua in vitro. Am J Obstet Gynecol 1983; 145: 744-748.
127. 2) receptors in the porcine placenta and fetal membranes. Placenta 1996; 17: 147-153.
128. Pucell AG, Hodges JC, Sen I, Bumpus FM, Husain A. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology 1991; 128: 1947-1959.
129. Kambayashi Y, Bardhan S, Takahasi K, Tsuzuki S, Inui H, Hamakubo T, et al. Molecular cloning of a novel angiotensin-II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993; 268: 24543-24546.
130. 2 receptors do not interact with guanine nucleotide binding proteins. Eur J Pharmacol 1991; 207: 157-163.
131. Schirar A, Capponi A, Catt KJ. Elevation of uterine angiotensin II receptors during early pregnancy in the rat. Endocrinology 1980; 106: 1521-1527.
132. Brar HS, Kjos SL, Dougherty W, Do YS, Tam HB, Hsueh WA. Increased fetoplacental active renin production in pregnancy-induced hypertension. Am J Obstet Gynecol 1987; 157: 363-367.
133. 2) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther 1994; 271: 1007-1015.
134. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988; 71: 122-137.
135. Chao HS, Poisner AM, Poisner R, Handwerger S. Lipopolysaccharides inhibit prolactin and renin release from human deciduacells. Biol Reprod 1994; 50: 210-214.
136. Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994; 96: 451-456.
137. Editorial. Are ACE inhibitors safe in pregnancy? Lancet 1989; 26: 482-483.
138. Barr M, Cohen MM. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 1991; 44: 485-495.
139. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991; 78: 128-135.
140. Howard RB, Pucell AG, Bumpus FM, Husain A. Rat ovarian renin: characterization and changes during the estrous cycle. Endocrinology 1988; 123: 2331-2340.
141. Fernandez LA, Tarlatzis BC, Rzasa PJ, Caride VJ, Laufer N, Negro Vilar AF, et al. Renin-like activity in ovarian follicular fluid. Fertil Steril 1985; 44: 219-223.
142. Derkx FH, Alberda AT, Zeilmaker GH, Schalekamp MA. High concentrations of immunoreactive renin. prorenin and enzymatically-active renin in human ovarian follicular fluid. Br J Obstet Gynaecol 1987; 94: 4-9.
143. Glorioso N, Atlas SA, Laragh JH, Jewelewicz R, Sealey JE. Prorenin in high concentrations in human ovarian follicular fluid. Science 1986; 233: 1422-1424.
144. Nielsen AH, Hagemann A, Avery B, Poulsen K. Differences in expression of angiotensin II receptors and renin in porcine and bovine ovaries. Exp Clin Endocrinol 1995; 103: 332-338.
145. Palumbo A, Jones C, Lightman A, Carcangiu ML, DeCherney AH, Naftolin F. Immunohistochemical localization of renin and angiotensin H in human ovaries. Am J Obstet Gynecol 1989; 160: 8-14.
146. Feral C, Reznik Y, Le Gall S, Mahoudeau J, Corvol P, Leymarie P. Stimulation by hCG of ovarian inactive renin synthesis in rabbit preovulatory theca cells. J Reprod Fertil 1990; 89: 407-414.
147. Palumbo A, Pourmotabbed G, Carcangiu ML, Andrade Gordon P, Roa L, DeCherney A, et al. Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil Steril 1993; 60: 280-284.
148. Cabrera RR, Guardia DC, De Vito E. A renin-like enzyme in luteal tissue. Mol Cell hndocrinol 1986; 47: 269-273.
149. Lightman A, Tarlatzis BC, Rzasa PJ, Culler MD, Caride VJ, Negro Vilar AF, et al. The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulatcd human follicular fluid. Am J Obstet Gynecol 1987; 156: 808-816.
150. Paulson RJ, Do YS, Hsueh WA, Eggena P, Lobo RA. Ovarian renin production in vitro and in vivo: characterization and clinical correlation. Fertil Steril 1989; 51: 634-638.
151. Brameld JM, Pipkin FB, Symonds EM. Studies on the human ovarian renin-angiotensin system: optimization of assay methodology and effects of follicular stimulants. J Endocrinol 1990; 127: 513-521.
152. Ireland JJ, Roche JF. Development of antral follicles in cattle after prostaglandin-induced luteolysis: changes in serum hormones, steroids in follicular fluid, and gonadotropin receptors. Endocrinology 1982; 111: 2077-2086.
153. Ireland JJ, Roche JF. Growth and differentiation of large antral follicles after spontanous luteolysis in heifers: change in concentration of hormones in follicular fluid and specific binding of gonadotropins to follicles. J Anim Sci 1983; 57: 157-167.
154. Fortune JE, Hansel W. Concentrations of steroids and gonadotropins in follicular fluid from normal heifers and heifers primed for superovulation. Biol Reprod 1985; 32: 1069-1079.
155. Callesen H, Greve T, Hyttel P. Preovulatory endocrinology and oocyte maturation in superovulated cattle. Theriogenology 1986; 25: 71-86.
156. Kruip TAM, Dieleman SJ. Steroid hormone concentrations in the fluid of bovine follicles relative to size, quality and stage of the oestrus cycle. Theriogenology 1985; 24: 395-408.
157. Mukhopadhyay AK, Holstein K, Szkudlinski M, Brunswig Spickenheier B, Leidenberger FA. The relationship between prorenin levels in follicular fluid and follicular atresia in bovine ovaries. Endocrinology 1991; 129: 2367-2375.
158. Itskovitz J, Rubattu S, Rosenwaks Z, Liu HC, Sealey JE. Relationship of follicular fluid prorenin to oocyte maturation, steroid levels, and outcome of in vitro fertilization. J Clin Endocrinol Metab 1991; 72: 165-171.
159. Sato Y. Renin- and angiotensin-like immunoactivities in human ovarian follicular fluid in in vitro fertilization. Horm Res 1991; 35 Suppl 1: 47-49.
160. Cornwallis CM, Skinner SL, Nayudu PL, Lopata A, Thatcher RL, Yeung SP, et al. Follicular fluid renin concentration and IVF outcome. Hum Reprod 1990; 5: 413-417.
161. Adashi EY. The Ovarian Cycle. In: Yen SSC, Jaffe RB, eds Reproductive Endocrinology. 3rd ed. Philadelphia: W.B. Saunders Company. 1991: 181-237.
162. Brunswig Spickenheier B, Mukhopadhyay AK. Inhibitory effects of a tumor-promoting phorbol ester on luteinizing hormone-stimulated renin and prorenin production by cultured bovine theca cells. Endocrinology 1990; 127: 2157-2165.
163. Sealey JK, Glorioso N, Itskovitz J, Atlas SA, Pitarresi TM, Preibisz JJ, et al. Ovarian prorenin. Clin Exp Hypertens A 1987; 9: 1435-1454.
164. Do YS, Sherrod A, Lobo RA, Paulson RJ, Shinagawa T, Chen SW, et al. Human ovarian theca cells are a source of renin. Proc Natl Acad Sci USA 1988; 85: 1957-1961.
165. Itskovitz J, Bruneval P, Soubrier F, Thaler I, Corvol P, Sealey JE. Localization of renin gene expression to monkey ovarian theca cells by in situ hybridization. J Clin Endocrinol Metab 1992; 75: 1374-1380.
166. Richards JS. Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev 1980; 60: 51-89.
167. Brunswig Spickenheier B, Mukhopadhyay AK. Effects of tumor necrosis factor- on luteinizing hormone-stimulated prorenin production by bovine ovarian theca cells in vitro. Endocrinology 1993; 133: 2515-2522.
168. Thomas WG, Sernia C. The immunocytochemical localization of angiotensmogen in the rat ovary. Cell Tissue Res 1990; 261: 367-373.
169. Glorioso N, Troffa C, Tonolo G. Prorenin in the cells of the mature human ovarian follicle. Clin Exp Hypertens A 1988; 10: 1325-1327.
170. Ohkubo H, Nakayama K, Tanaka T, Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem 1986; 261: 319-323.
171. Daud AI, Bumpus FM, Husain A. Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation. Endocrinology 1990; 126: 2927-2935.
172. Speth RC, Husain A. Distribution of angiotensin-converting enzyme and angiotensin II-receptor binding sites in the rat ovary. Biol Reprod 1988; 38: 695-702.
173. Ezra Y, Simon A, Yaron A, Laufer N, Navot D. Angiotensin-I-converting enzyme and its correlation with human follicular fluid steroids. Eur J Obstet Gynccol Reprod Biol 1992; 44: 71-75.
174. Lightman A, Jones CL, MacLusky NJ, Palumho A, DeCherney AH, Naftolin F. Immunocytochemical localization of angiotensin II immunoreactivity and demonstration of angiotensin II binding in the rat ovary. Am J Obstet Gynecol 1988; 159: 526-530.
175. Yoshimura Y, Koyama N, Karube M, Oda T, Akiba M, Yoshinaga A, et al. Gonadotropin stimulates ovarian renin-angiotensin system in the rabbit. J Clin Invest 1994; 93: 180-187.
176. Einspanier A, Jarry H, Pitzel L, Holtz W, Wuttke W. Determination of secretion rates of estradiol, progesterone, oxytocin, and angiotensin II from tertiary follicles and freshly formed corpora lutea in freely moving sows. Endocrinology 1991; 129: 3403-3409.
177. 2 receptor expression in ovaries: a review. In: Raizada MKet al, eds. Recent advanges in cellular and molecular aspects of angiotensin receptors. New York: Plenum Press, 1996: 183-187.
178. Brunswig Spickenheier B, Mukhopadhyay AK. Characterization of angiotensin-II receptor subtype on bovine thecal cells and its regulation by luteinizing hormone. Endocrinology 1992; 131: 1445-1452.
179. Aguilera G, Millan MA, Harwood JP. Angiotensin II receptors in the gonads. Am J Hypertens 1989; 2: 395-402.
180. Pucell AG, Bumpus FM, Husain A. Rat ovarian angiotensin II receptors. Characterization and coupling to estrogen secretion. J Biol Chem 1987; 262: 7076-7080.
181. Daud AI, Bumpus FM, Husain A. Evidence for selective expression of angiotensin II receptors on atretic follicles in the rat ovary: an autoradiographic study. Endocrinology 1988; 122: 2727-2734.
182. Speth RC, Bumpus FM, Husain A. Identification of angiotensin II receptors in the rat ovary. Eur J Pharmacol 1986; 130: 351-352
183. Rainey WE, Bird IM, Byrd W, Carr BR. Effect of angiotensin II on human luteinized granulosa cells. Fertil Steril 1993; 59: 143-147.
184. Pepperell JR, Nemeth G, Yamada Y, Naftolin F. The type 1 angiotensin-II receptor mediates intracellular calcium mobilization in rat luteal cells. Endocrinology 1993; 133: 1678-1684.
185. Pucell AG, Bumpus FM, Husain A. Regulation of angiotensin II receptors in cultured rat ovarian granulosa cells by follicle-stimulating hormone and angiotensin II. J Biol Chem 1988; 263: 11954-11961.
186. Nielsen AH, Hagemann A, Poulsen K. The tissue renin-angiotensin system in the female reproductive tissues: a review. Advances in Experimental Medicine & Biology 1995; 377: 253-268.
187. Pellicer A, Palumbo A, DeCherney AH, Naftolin F. Blockage of ovulation by an angiotensin antagonist. Science 1988; 240: 1660-1661.
188. Peterson CM, Zhu C, Mukaida T, Butler TA, Woessner JFJ, LeMaire WJ. The angiotensin II antagonist saralasin inhibits ovulation in the perfused rat ovary. Am J Obstet Gynecol 1993; 168: 242-245.
189. Kuo TC, Endo K, Dharmarajan AM, Miyazaki T, Atlas SJ, Wallach EE. Direct effect of angiotensin II on in-vitro perfused rabbit ovary. J Reprod Fertil 1991; 92: 469-474.
190. Yoshimura Y, Karube M, Oda T, Koyama N, Shiokawa S, Akiba M, et al. Locally produced angiotensin II induces ovulation by stimulating prostaglandin production in in vitro perfused rabbit ovaries. Endocrinology 1993; 133: 1609-1616.
191. 2 receptor subtype. Endocrinology 1996; 137: 1204-1211.
192. Mcnatty KP. Follicular fluid. In: Jones RE, eds. The vertebrate ovary. New York: Plenum Press. 1978: 215-259.
193. Kitzman PH, Hutz RJ. In-vitro effects of angiotensin II on steroid production by hamster ovarian follicles and on ultrastructure of the theca interna. Cell Tissue Res 1992; 268: 191-196.
194. Usuki S, Saitoh T, Saitoh M, Tanaka J, Kawakura Y, Usuki Y, et al. Endothelin-renin-angiotensin-atrial natriuretic peptide system in ovaries: an intraovarian ERAANP system. J Cardiovasc Pharmacol 1993; 22(suppl.8): S207-S210.
195. Stirling D, Magness RR, Stone R, Waterman MR, Simpson ER. Angio- tensin II inhibits luteinizing hormone-stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture. J Biol Chem 1990; 265: 5-8.
196. Feral C, Le Gall S, Leymarie P. Angiotensin II modulates steroidogenesis in granulosa and theca in the rabbit ovary, its possible involvement in atresia. Eur J Endocrinol 1995; 133: 747-753.
197. Li XM, Juorio AV, Murphy BD. Angiotensin II interferes with steroidogenesis in porcine granulosa cells. Biol Reprod 1995; 53: 791-799.
198. Morris RS, Wong IL, Paulson RJ. Angiotensin converting enzyme inhibition of the gonadotropin-stimulatcd rabbit: effect on estradiol production J Assist Reprod Genet 1995; 12: 326-329.
199. Brunswig-Spickenheier B, Steinbach B, Mukhopadhyay AK. Paracrine regulation of the bovine ovarian prorenin-renin-angiotensin-system. Adv Exp Med Biol 1995; 377: 399-406.
200. Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985; 105: 141-145.
201. Morris RS, Wong IL, Hatch IE, Gentschein E, Paulson RJ, Lobo RA. Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism. Fertil Steril 1995; 64: 1099-1103.
202. Navot D, Margalioth EJ, Laufer N, Birkenfeld A, Relou A, Rosler A. et al. Direct correlation between plasma renin activity and seventy of the ovarian hyperstimulation syndrome. Fertil Steril 1987; 48: 57-61.
203. Morris RS, Wong IL, Kirkman E, Gentschein K, Paulson RJ. Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum Reprod 1995; 10: 1355-1358.